
Clinical trials of new medications and studies present an opportunity for pharmaceutical and biotechnology companies to ascertain the safety and effectiveness of their medications; for physicians to find new medications to help their patients; and for people with IBD to actively participate to assist their health and search for treatments for these diseases.
CCA does not endorse or ensure the scientific merit of trials listed in the registry. CCA plays an important role in bringing trials to the attention of potential participants, via sources such as its website. People who wish to participate in a trial should discuss the opportunity with their treating doctor.
We also have details of the Australian & New Zealand IBD Family Genetic Study, the National IBD Paediatric and Adolescent Database Project and various other IBD studies.
Please note that evaluating data from clinical trials is a lengthy process. We will publish results once they are made available to CCA. Thank you for your patience.
Questions to Ask Trial Investigator & Nurse
Patients enrolled in a trial are closely monitored throughout the trial by the clinical investigators. On the first visit, the patient can and should prepare a list of questions and any concerns, to order to ask the investigator and nurse, questions such as;
-
What are the advantages and disadvantages?
-
What is the purpose of the trial and how long will it last?
-
Who has reviewed the trial and approved the trial?
-
What kind of tests, procedures and treatments are involved?
-
How often would I require follow up test etc?
-
What are the side effects of the treatment?
-
Will there be any pain or discomfort?
-
Is the treatment in the form of a pill or injection?
-
Will the treatment be free?
-
When the trial is finished, if I respond, can I still continue on with the treatment if I need to?
-
How many visits to the center are involved?
-
If I am harmed during the trial, what treatment would I be entitled to?
-
What are my treatment options, other than this medication?
-
Who do I call if I experience a side effect during the trial?
-
Will my personal doctor receive progress reports?
-
If I don't understand some of the informed consent information, who do I call?
-
Who is the sponsor of the trial (what company)?
Other Resources:







